Fig 2.

Practical workflow process for coronavirus disease 2019 (COVID-19) test and surveillance. ∗COVID-19 Test: Naso-oropharyngeal swab, nucleic acid test (NAT) to detect COVID-19 RNA by polymerase chain reaction (PCR), in a designated drive-through area. ^★Severe symptoms: Severe shortness of breath, hypoxia, hypotension, acute chest pain, or confusion. ^†To call 911 for a transfer to hospital emergency department. ^‡Telemedicine via a synchronous video visit for clinical assessment and management. ^ǁHospitalization through an emergency department admission or an arranged direct admission to COVID-19 inpatient unit. ^§To self-quarantine per Centers for Disease Control and Prevention (CDC) guidelines and to keep home log of vital signs twice daily in the first 2 weeks. Patients are instructed to seek immediate medical attention if symptoms worsening. To be followed-up by a transplant coordinator via telephone calls twice weekly and transplant nephrologist via telemedicine video visits close to two-week post COVID-19 diagnosis and thereafter as clinically determined. ∗∗Patient needs to return to laboratory test, procedure, or work that cannot be performed remotely and that will occur within 6 weeks of symptom onset. Decisions regarding the duration of self-quarantine are subject to change in consultation with infectious disease experts. ^¶To repeat COVID-19 NAT at 2 weeks post–COVID-19 diagnosis twice weekly until it is converted negative on 2 consecutive occasions before returning to laboratory test, procedure, or work.